Life science industry organisations BioMelbourne Network, AusBiotech and Research Australia have united to launch a ‘postcard petition’ to alert the federal government to the potential damage from the proposed changes to the R&D Tax Incentive.
The R&D Tax Incentive supports Australia’s current and future capacity to meet the increasing global demand for healthcare and innovation.
We strongly oppose the introduction of a $2 million cap on the annual cash refund payable under the R&D Tax Incentive. We believe the proposed cap will negatively impact Australia’s ability to be globally competitive in public and private medical research, clinical trials, advanced manufacturing, STEM jobs and other areas critical to the development of the life sciences industry.
BioMelbourne Network urges members to complete the postcard, available now by: printing the card and ideally including with it a letter outlining how the proposed changes to the R&D Tax Incentive will impact your company, or joint the conversation on Twitter: #NoRandDcap
If you would like us to send you some postcards, please call us on 9667 8181.